Nearly a decade after the Pharmaceutical Society of Ghana (PSGH) began implementing its 2016–2025 Strategic Plan, the Society has taken a hard look at what changed, what worked, and what still needs to be done. At the just-ended 90th Anniversary Annual General Meeting and Scientific Conference, the PSGH Strategic Plan Manager, Dr. (Pharm) Harry Amoaning Okyere, presented both the 2025–2026 implementation report and a broader retrospective review of the strategy since implementation began in 2017.

The picture that emerged was one of a Society that has grown significantly in size, visibility, institutional strength and programme delivery, while also recognising that the next strategic era must be much stronger on measurable outcomes.

The review found that across 36 implementation domains, seven had been achieved or were becoming institutionalised, 16 showed substantial progress, 10 were partially implemented, and three remained largely at planning or evidence-deficient stage. Overall implementation maturity was estimated at about 3.0 out of 5, a finding that points to meaningful progress, but also unfinished business.

Some of the numbers tell the story vividly.

Professional development emerged as one of the clearest success stories.  Member welfare recorded equally striking progress. The PSGH-GLICO insurance scheme moved from a voluntary initiative to a structured member benefit embedded in dues, with substantial claims paid to beneficiaries. The wider review described insurance and immediate welfare protection as one of the Society’s most institutionalised achievements.

The decade also saw PSGH become more active in pharmacist entrepreneurship and access to finance. Through pharmacy licence support, SEAPS and related financing arrangements, more pharmacists received assistance to establish or strengthen pharmacy businesses. At the same time, the Society expanded its grant mobilisation capacity and progressed work on the PSGH Pharmacy Centre, one of its most significant institutional investments.

The current implementation year added fresh momentum. Between September 2025 and September 2026, PSGH reported progress in national primary-healthcare advocacy, maternal and neonatal health interventions through community pharmacies, pharmacy-business financing, research and professional capacity building, and new national and international partnerships.

Digital transformation has also moved to centre stage. PSGH initiated development of a Unified Digital Platform intended to integrate membership management, dues payments, CPD tracking, events, job opportunities, e-voting, welfare processes, the Ghana Pharmaceutical Journal and other core systems into one ecosystem.

But the presentation was not simply a celebration of achievements.

The review was equally candid about the weaknesses of the original plan. Many objectives lacked clear baselines, measurable annual targets, accountable owners and outcome indicators. As a result, PSGH was often able to show what had been launched, organised or advocated for, but not always what changed because of those interventions. This was particularly evident in areas such as patient-care outcomes, medicine availability and affordability, local manufacturing, conditions of service, professional remuneration and national access to pharmaceutical care.

The review therefore recommends a major shift in how PSGH manages strategy going forward: shorter operational planning cycles, stronger monitoring and evaluation, a central digital dashboard, standardised reporting across regions and practice groups, and an annual strategic scorecard that distinguishes activities from real outcomes.

The broader lesson from the decade was perhaps the most important.

PSGH has become larger, more digital, more project-driven, more visible in national policy discussions and stronger in member welfare and institutional development. What comes next is making those gains easier to measure, compare and sustain. For a Society celebrating 90 years of pharmaceutical excellence, that marks an important transition: from counting activities to counting impact; from having a strategic plan to building a true strategic performance system.